Heidenhain variant of Creutzfeldt-Jakob disease: Diffusion-weighted MRI and PET characteristics

被引:20
作者
Tsuji, Y
Kanamori, H
Murakami, G
Yokode, M
Mezaki, T
Doh-ura, K
Taniguchi, K
Matsubayashi, K
Fukuyama, H
Kita, T
Tanaka, M
机构
[1] Kyoto Univ, Dept Geriatr Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan
[3] Kyoto Univ, Dept Funct Brain Imaging, Grad Sch Med, Human Brain Res Ctr, Kyoto 6068507, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan
[5] Kyoto Univ, Translat Res Ctr, Fac Med, Kyoto 6068507, Japan
[6] Kyushu Univ, Dept Neuropathol, Neurol Inst, Fukuoka 812, Japan
[7] Kyoto Univ, Ctr SE Asian Studies, Kyoto 6068507, Japan
关键词
Creutzteldt-Jakob disease; visual disturbance; 14-3-3; protein; diffusion-weighted MRI; PET; visual evoked potentials;
D O I
10.1177/1051228403258147
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Creutzfeldt-Jakob disease (CJD) is characterized by rapidly progressive dementia with a variety of neurological disorders and a fatal outcome. The authors present a case with visual disturbance as a leading symptom and rapid deterioration in global cognitive functions. The cerebrospinal fluid was positive for 14-3-3 protein, and diffusion-weighted magnetic resonance imaging (MRI) showed marked hyperintensity in the parieto-occipital cortices, where hypometabolism was clearly detected on positron emission tomography (PET). Pattern -reversal visual evoked potentials showed prolonged P100 latencies and increased N75/P100 amplitudes. All these findings supported a diagnosis of the Heidenhain variant of CJD, whereas a long clinical course, a lack of myoclonus, and an absence of periodic synchronous discharges on electroencephalography were atypical. Diffusion-weighted MRI and PET in combination with visual evoked potential recording and 14-3-3 protein detection may be useful for the early diagnosis of CJD.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 27 条
[1]   SENSORY EVOKED-POTENTIALS IN CREUTZFELDT-JAKOB DISEASE [J].
AGUGLIA, U ;
FARNARIER, G ;
REGIS, H ;
OLIVERI, RL ;
QUATTRONE, A .
EUROPEAN NEUROLOGY, 1990, 30 (03) :157-161
[2]   Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease [J].
Bahn, MM ;
Parchi, P .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :577-583
[3]   Diagnosis of Creutzfeldt-Jakob disease -: Effect of clinical criteria on incidence estimates [J].
Brandel, JP ;
Delasnerie-Lauprêtre, N ;
Laplanche, JL ;
Hauw, JJ ;
Alpérovitch, A .
NEUROLOGY, 2000, 54 (05) :1095-1099
[4]   Creutzfeldt-Jakob disease -: Neurophysiologic visual impairments [J].
de Seze, J ;
Hache, JC ;
Vermersch, P ;
Arndt, CF ;
Maurage, CA ;
Pasquier, F ;
Laplanche, JL ;
Ruchoux, MM ;
Leys, D ;
Destée, A ;
Petit, H .
NEUROLOGY, 1998, 51 (04) :962-967
[5]   Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease [J].
Demaerel, P ;
Heiner, L ;
Robberecht, W ;
Sciot, R ;
Wilms, G .
NEUROLOGY, 1999, 52 (01) :205-208
[6]  
Eschweiler GW, 2002, NERVENARZT, V73, P883, DOI 10.1007/s00115-002-1360-x
[7]   MR imaging of Creutzfeldt-Jakob disease [J].
Finkenstaedt, M ;
Szudra, A ;
Zerr, I ;
Poser, S ;
Hise, JH ;
Stoebner, JM ;
Weber, T .
RADIOLOGY, 1996, 199 (03) :793-798
[8]   Giant visually-evoked potentials without myoclonus in the Heidenhain type of Creutzfeld-Jakob disease [J].
Finsterer, J ;
Bancher, C ;
Mamoli, B .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 167 (01) :73-75
[9]   Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease [J].
Green, AJE .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :382-386
[10]  
Grunwald F, 1996, Ann Nucl Med, V10, P131